A simple urine test can help detect the recurrence of bladder cancer and is more accurate than conventional laboratory tests. Nuclear matrix protein 22 (NMP 22) (BladderChek, Matritech) used with a ...
A significant number of patients with non-muscle-invasive transitional-cell carcinoma (TCC) of the bladder will experience tumor recurrence and progression following treatment. Risk stratification ...
Physicians now have a more dependable, less expensive tool to help detect bladder cancer earlier. Researchers at The University of Texas M. D. Anderson Cancer Center found that a simple test that can ...
Physicians now have a tool to help monitor patients with a history of bladder cancer that is four times more effective than the conventional laboratory test in detecting the disease, according to a ...
Nuclear matrix protein-22 (NMP22) is approved for clinical use by the FDA. However, the UroScreen study—the largest prospective validation study for early detection of bladder cancer—has concluded ...
Please provide your email address to receive an email when new articles are posted on . A urinary DNA methylation test outperformed the nuclear matrix protein 22 test or urine cytology test.
Impact of clinicopathological features on survival in patients treated with immune-based combinations for metastatic urothelial carcinoma: A meta-analysis of randomized clinical trials. This is an ...
It has a high sensitivity and specificity for predicting the cancer’s presence, researcher says. With upper tract transitional cell carcinoma (UTTCC), vigilance is the watchword. Detecting this cancer ...
Researchers led by the University of Ulsan College of Medicine, Korea, have checked the performance of a noninvasive urinary ...
Firefighters are at higher risk for certain kinds of cancer–that’s an established fact. But many firefighters still lack information about specific risks–and what they can do to protect themselves.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback